Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

July 26, 2017

Coping With Cancer-Related Fatigue

Author(s):

Jane Biehl Ph.D.

A cancer survivor attempts to explain the extreme fatigue endured by the patient undergoing chemo.

It is early afternoon, and I am enjoying lunch with my friends. We are laughing, talking and having a great time.

Without warning, their voices begin to fade and I can no longer concentrate. I excuse myself politely, pay my check and drive home. I immediately fall into bed and sleep for the next couple of hours. Frustrating as this is, I needed to do that before I could finish my chores for the rest of the day.

I slept in this morning and feel good. I take my service dog and do grocery shopping and run errands. When we return home, she is by the door ready for her daily walk. I collapse between the sheets to sleep before I have enough energy to take her.

I have paid a handsome price to see a real live theater play I love. I am relaxed and listening to the music. Suddenly my eyes close and I am struggling to stay awake.

Welcome to the world of real fatigue. The combination of cancer and chemo makes me chronically, unremittingly and forever tired. When I mention this as a side effect, only people with cancer and other chronic conditions can really “get it.”

I am on constant chemo and will be forever, but even people who have stopped chemo tell me they still are tired for years afterwards. This makes sense if you realize that chemo is pouring poison into your system to destroy the bad cells, but is also attacking the good ones. This makes the fatigue is unavoidable. I think most of us have figured out our chemo cycles so that we have an idea how long it will take to get at least some of our energy back before the next round.

In my experience, it does no good to try and explain the amount of fatigue cancer survivors go through. I put in all-nighters in college, many long days and nights working two jobs, stayed up countless nights writing a dissertation, and have been in the emergency room until the wee hours of the morning with relatives. The big difference was this — after a night’s sleep, I felt better. With chemo, fatigue is a tiredness that never goes away.

So how do I cope? If I mention to someone that I am tired from the chemo and they say, “Oh yes, I am getting older and I know what you mean,” I just smile and nod. I was working two part-time jobs when I started the chemo. Over the six years, I was on oral dosages I was forced to quit one job. When I switched to shots in the stomach and arms five days a month, I reluctantly quit the second one. I honestly feel guilty about the fatigue and that I have to take naps. That old voice instilled by my parents about “never being idle” still echoes in my head.

The only way I can handle this is self-talk. I need to remind myself that sleeping this much is not laziness, but part of the healing process. I can beat myself up, but then realize I am still alive! I am exhausted, but I do the best I can. If that means more naps, so be it.

I have been forced to realize that I can no longer work an eight-hour day and then come home and do a bunch of stuff around the house. I may putter around or go out and get groceries or be with friends. I may function for four hours or two hours or one hour or none. But I am enjoying another wonderful day.

Hey, I never said it was easy. I still feel guilty after seven years for “slacking off.” I also have learned a great deal.

It is fun to go out on my patio and have a cup of coffee whenever I feel like it. My dog loves her belly rubs. My cat enjoys my lap. There are lots of good books to read. If I want to spend lazy times on Facebook that is OK. Yes, I have seen that version of “Law and Order” before, but I like that show. And my friends enjoy my staying and talking over lunch or dinner, instead of hurrying home to grade papers like I did when I was teaching. The sunsets I get to watch are beautiful.

Yes, I am constantly tired. Yes, I want to do more. But there is much more to life than working all the time. Naps and laying around isn’t so bad either. I am happy to be here on earth for a little while longer.

Sorry — I am tired now and have to go take a nap!

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content
Advertisement
The FDA approved Zegfrovy for advanced NSCLC with EGFR exon 20 mutations after chemotherapy: stock.adobe.com.
July 2nd 2025

Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer

Spencer Feldman
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice.
July 2nd 2025

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

Spencer Feldman
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
July 2nd 2025

FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma

Spencer Feldman
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
Image of Valarie with text.
July 2nd 2025

Living After Cancer: A Cancer Thriver Shares Her Story

Ryan Scott
Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.
Related Content
Advertisement
The FDA approved Zegfrovy for advanced NSCLC with EGFR exon 20 mutations after chemotherapy: stock.adobe.com.
July 2nd 2025

Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer

Spencer Feldman
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice.
July 2nd 2025

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

Spencer Feldman
Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
July 2nd 2025

FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma

Spencer Feldman
The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
Image of Valarie with text.
July 2nd 2025

Living After Cancer: A Cancer Thriver Shares Her Story

Ryan Scott
Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.